Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Manjit, Matharu"'
Autor:
Michel Lanteri-Minet, Elizabeth Leroux, Zaza Katsarava, Richard B. Lipton, Fumihiko Sakai, Manjit Matharu, Kristina Fanning, Aubrey Manack Adams, Katherine Sommer, Michael Seminerio, Dawn C. Buse
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Objective To assess rates of traversing barriers to care to access optimal clinical outcomes in people with migraine internationally. Background People in need of medical care for migraine should consult a health care professional knowledgea
Externí odkaz:
https://doaj.org/article/35d3951a2ed94226982c1beef0ccd5ab
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Extra-articular symptoms, including headaches, are frequently encountered in patients with Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders (HSD), and may be the presenting complaint. Migraine is reported in up to three quarters of p
Externí odkaz:
https://doaj.org/article/8eeb428227974748abdf101667c08e8c
Autor:
Hema Mistry, Seyran Naghdi, Anna Brown, Sophie Rees, Jason Madan, Amy Grove, Saval Khanal, Callum Duncan, Manjit Matharu, Andrew Cooklin, Aiva Aksentyte, Natasha Davies, Martin Underwood
Publikováno v:
Health Technology Assessment, Vol 28, Iss 63 (2024)
Background Chronic migraine is a disabling condition, affecting 2–4% of adults globally. With the introduction of expensive calcitonin gene-related peptide monoclonal antibodies, it is timely to compare the clinical effectiveness and cost-effective
Externí odkaz:
https://doaj.org/article/8955477c7f164bd1b32be3dc6056e1f6
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Migraine is the world’s second most common disabling disorder, affecting 15% of UK adults and costing the UK over £1.5 billion per year. Several costly new drugs have been approved by National Institute for Health and Care Exce
Externí odkaz:
https://doaj.org/article/c790a979b0654b1492c572de453afa6e
Autor:
Seyran Naghdi, Martin Underwood, Jason Madan, Anna Brown, Callum Duncan, Manjit Matharu, Aiva Aksentyte, Natasha Davies, Sophie Rees, Andrew Cooklin, Amy Grove, Hema Mistry
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Chronic migraine can be a profoundly disabling disorder that may be treated with preventive medications. However, uncertainty remains as to which preventive medication is the most effective. We present a network meta-analysis to d
Externí odkaz:
https://doaj.org/article/4c645cfa4fcb4973b6e2f709052a3b5d
Autor:
Manjit Matharu, Jason Charles Ray, Elspeth Jane Hutton, Shuli Cheng, Josephine Baker, Linda Dalic
Publikováno v:
BMJ Neurology Open, Vol 6, Iss 1 (2024)
Introduction Clinical trials show that calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) are effective preventative treatments for chronic migraine. Their efficacy over longer time periods and in cohorts originally excluded from trial
Externí odkaz:
https://doaj.org/article/f8992acb26ee44dbbf949cab754713ae
Autor:
Martin Underwood, Hema Mistry, Manjit Matharu, Callum Duncan, Anna Brown, Seyran Naghdi, Natasha Davies, Aiva Aksentyte
Publikováno v:
BMJ Neurology Open, Vol 6, Iss 1 (2024)
Background Migraine is the second most common prevalent disorder worldwide and is a top cause of disability with a substantial economic burden. Many preventive migraine medications have notable side effects that affect different body organs.Method We
Externí odkaz:
https://doaj.org/article/cee79869561a466a95aa41403ca36e34
Autor:
Sanjay Cheema, Anker Stubberud, Khadija Rantell, Parashkev Nachev, Erling Tronvik, Manjit Matharu
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background It is unknown whether new daily persistent headache (NDPH) is a single disorder or heterogenous group of disorders, and whether it is a unique disorder from chronic migraine and chronic tension-type headache. We describe a large g
Externí odkaz:
https://doaj.org/article/be7d3ee548224a6da4a2bac711f4845a
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background The role of inflammation and cytokines in the pathophysiology of primary headache disorders is uncertain. We performed a systematic review and meta-analysis to synthesise the results of studies comparing peripheral blood cytokine
Externí odkaz:
https://doaj.org/article/4597df2c815746dc8fdb1675f9873c48
Autor:
Kamran Khan, Hema Mistry, Manjit Matharu, Chloe Norman, Stavros Petrou, Kimberley Stewart, Martin Underwood, Felix Achana
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background The Headache Impact Test (HIT-6) and the Chronic Headache Questionnaire (CH-QLQ) measure headache-related quality of life but are not preference-based and therefore cannot be used to generate health utilities for cost-effectivenes
Externí odkaz:
https://doaj.org/article/dc7a725b6d0a4b6e86d9708b0db424a2